BI 1950 |
BI 1950 : Inhibitor of ITGAL
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| ITGAL |
|
|
Inhibitor
100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selectivity within target family: Selective (>1000 fold) against closely related ITGB2 and ITGB1.
Se ...
Potency Cellular
In Vitro
ITGAL
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1002/jlcr.3698
In Vivo Validations
Mouse
Dose: 3 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
7.2 h
Systemic clearance:
8 %QH
Bioavailability:
154%
Volume of Distribution at Steady-State:
3.3 L/Kg
DOI Reference: 10.1002/jlcr.3698
Dose: 3 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
6.5 h
Systemic clearance:
11 %QH
Bioavailability:
21%
Volume of Distribution at Steady-State:
2.7 L/Kg
DOI Reference: 10.1002/jlcr.3698
Negative Control Compounds
BI 9446
Notes: Inhibits binding to ICAM1, Kd > 1000 nM; Inhibits SEB-induced production of IL2 in human PBMC, IC50 > 1000 nM; Clean GPCR scan except for activity on TMEM97 (Ki = 557.65 nM)
Chemical Information
| Molecular Formula | C32H26Cl2FN7O3 |
| SMILEs | C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1 |
| InChI | InChI=1S/C32H26Cl2FN7O3/c1-18(27(43)40-32(10-11-32)25-5-3-4-12-37-25)39-28(44)24-17-38-30-41(21-13-22(33)26(35)23(34)14-21)29(45)31(2,42(24)30)15-19-6-8-20(16-36)9-7-19/h3-9,12-14,17-18H,10-11,15H2,1-2H3,(H,39,44)(H,40,43)/t18-,31+/m0/s1 |
| Molecular weight | 645.15 Da |
| AlogP | 5.155680000000005 |
| HBond acceptors | 10 |
| HBond donors | 2 |
| Atoms | 71 |